Condition
Pediatric Acute Lymphoblastic Leukemia
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07374315Not ApplicableNot Yet Recruiting
Weight Gain in Pediatric Leukemia Survivors
NCT07403630Not ApplicableRecruiting
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
NCT06184009Phase 2RecruitingPrimary
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
NCT05866887Not ApplicableCompletedPrimary
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
Showing all 4 trials